# Endothelial Facilitation in Alzheimer's Disease

> **NCT01439555** · PHASE2 · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 11 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** L-Arginine
- **DRUG:** Tetrahydrobiopterin

## Key facts

- **NCT ID:** NCT01439555
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01439555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01439555, "Endothelial Facilitation in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01439555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*